V-Go reimbursement assistance program

Coverage and Cost Savings made simple

 

Broad insurance coverage and potential cost savings

No co-pays for long acting insulin or needles

Chart comparing V-Go to MDI

V-Go is reimbursed by Medicare Part D and most Commercial Insurance.

  • Fewer co-pays1
  • Less insulin2

Need help with reimbursement? We’re your partner in finding answers

Your partner at V-Go Customer Care can also assist you with any reimbursement questions you may have.

  • Simply call V-Go Customer Care at 1-866-881-1209. It will be helpful to have your insurance information on hand
  • We’ll contact your insurance provider with you to find out if they cover V-Go and conduct an in-depth benefits investigation
  • We can also provide support and answer any questions related to getting V-Go filled at the pharmacy
Not sure if you’re covered? Click here to have us check for you.

V-Go Cost Savings Card

With the V-Go Cost Savings Card, commercially insured patients pay $0 for the first prescription at any retail pharmacy. Refills cost $30 or $80 depending on insurance benefit.§

Here’s what you need to do to start saving.

  1. Simply download and print the card. (Cards have no expiration date.||)
  2. Activate it by calling the toll-free number on the card.
  3. Present the card to your pharmacist for savings.
  4. Start saving!

Download Card

30-day supply.
§$30 if drug benefit covered; $80 if drug benefit not covered.
||30 day public notice of cancellation.
This card is NOT valid for prescriptions that may be reimbursed under a federal or state healthcare program, including Medicare, Medicaid, or any other similar federal or state healthcare program, including any state pharmacy assistance program. This card is only valid for insured patients.

Request your FREE V-Go Demo

Free yourself from several insulin shots every day with the treatment option you apply like a patch

Want to see V-Go for yourself? Have a FREE Demo shipped to you.

References: 1. Sutton D, Higdon C, Carmon M, Martinez J, Peasah S. Evaluating cost of therapy and clinical efficacy with V-Go® in patients with sub-optimally controlled diabetes from an endocrine specialty system. Presented at [Carla Nikkel] the Academy of Managed Care Pharmacy Annual Meeting, San Francisco, CA. April 2016. [Poster] 2. Lajara R, Nikkel C. Evaluation of real-world clinical and pharmacy budget outcomes when switching to a wearable insulin delivery device for insulin administration in patients with sub-optimally controlled diabetes. Presented at: ISPOR 22nd Annual International Meeting, Boston MA. May 2017 [Poster]

Important Risk Information
If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Wearable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.